Alejandra Mørk

Alejandra Mørk is the CEO and main shareholder of KLIFO. Previously, she worked for Nycomed Pharma for 18 years, in various management positions in drug development and lifecycle management. Alejandra is a board member of Danish Biotech and a member of the Danish Academy of Technical Sciences. She is also part of the EUCROF Paediatric Working Group.